Martha Altieri
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
Papers in
-
- Multiple Myeloma Research and Treatments 4
- Genetics 4
- Diabetes and associated disorders 4
- Co-authors
- Jing Wang (3 shared papers)Jing Lü (3 shared papers)Kanak Raina (4 shared papers)Yimin Qian (4 shared papers)Andrew P. A. Crew (4 shared papers)Kevin G. Coleman (4 shared papers)James D. Winkler (3 shared papers)Craig M. Crews (4 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)European Journal of Cancer (1 paper)Diabetes (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Martha Altieri
9 papers receiving 2.0k citations
Martha Altieri's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 542
- Molecular Biology 1.6k
- Oncology 531
- Genetics 308
- Immunology 222
Countries citing papers authored by Martha Altieri
This map shows the geographic impact of Martha Altieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Altieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Altieri more than expected).
Fields of papers citing papers by Martha Altieri
This network shows the impact of papers produced by Martha Altieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Altieri. The network helps show where Martha Altieri may publish in the future.
Co-authors
The 25 scholars most cited alongside Martha Altieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Hit paper breakdown → | 2015 | 947 |
| 2 | PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Hit paper breakdown → | 2016 | 732 |
| 3 | 1998 | 140 | |
| 4 | 2000 | 90 | |
| 5 | 1997 | 61 | |
| 6 | 1998 | 54 | |
| 7 | 2005 | 20 | |
| 8 | 2015 | 4 | |
| 9 | 2016 | 3 |
About Martha Altieri
Martha Altieri is a scholar working on Hematology, Genetics, Immunology, Oncology and Molecular Biology, having authored 9 papers that have together received 2.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Diabetes and associated disorders (4 papers), Multiple Myeloma Research and Treatments (4 papers), Pancreatic function and diabetes (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Hematology (542 citations), Molecular Biology (1.6k citations), Oncology (531 citations), Genetics (308 citations) and Immunology (222 citations). Martha Altieri has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Jing Wang, Jing Lü, Kanak Raina, Yimin Qian, Andrew P. A. Crew, Kevin G. Coleman, James D. Winkler, Craig M. Crews, Hanqing Dong and John F. Hines. Their work appears in journals such as Journal of Clinical Investigation, Bioorganic & Medicinal Chemistry Letters, European Journal of Cancer, Diabetes and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.